Crosstalk between kidney and bone: insights from CKD-MBD
Journal of Bone and Mineral Metabolism · 2024-07 · 42 (4) · 463-469
DOI: 10.1007/s00774-024-01528-0 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Bone and Mineral Metabolism, online erschienen am 26.07.2024. Verfasst von Kodai Suzuki und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine, 143 Shimokasuya, Isehara, 259-1193, Japan. Hauptthemen laut MEDLINE: Fibroblast Growth Factor-23, Chronic Kidney Disease-Mineral and Bone Disorder, Bone and Bones, Kidney. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 55 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine, 143 Shimokasuya, Isehara, 259-1193, Japan.
- Department of Nephrology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
- Division of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine, 143 Shimokasuya, Isehara, 259-1193, Japan. hkomaba@tokai.ac.jp.
- The Institute of Medical Sciences, Tokai University, Isehara, Japan. hkomaba@tokai.ac.jp.
Zitieren
APA
Suzuki, K., Soeda, K., & Komaba, H. (2024). Crosstalk between kidney and bone: insights from CKD-MBD. Journal of Bone and Mineral Metabolism, 42(4), 463-469. https://doi.org/10.1007/s00774-024-01528-0
Vancouver
Suzuki K, Soeda K, Komaba H. Crosstalk between kidney and bone: insights from CKD-MBD. Journal of Bone and Mineral Metabolism. 2024;42(4):463-469. doi:10.1007/s00774-024-01528-0
BibTeX
@article{Suzuki2024,
author = {Suzuki, Kodai and Soeda, Keisuke and Komaba, Hirotaka},
title = {Crosstalk between kidney and bone: insights from CKD-MBD},
journal = {Journal of Bone and Mineral Metabolism},
year = {2024},
volume = {42},
number = {4},
pages = {463--469},
doi = {10.1007/s00774-024-01528-0}
}
EUVIMED